Wegovy Microdosing: The Real Story and 7 Actual Options in 2026

Where can you get Wegovy-style microdosing? The 7 options, one by one

Five sellers use compounded semaglutide, the medicine in Wegovy, made by a pharmacy for one patient. Compounded medicine is not FDA-approved. Two options use the real, brand-name Wegovy pill at its lowest doses. Start with the line that sounds like you:

• Lowest price: Mochi Health, about $140 a month at the lowest dose.
• Brand-name drug, lowest price: the Wegovy pill through NovoCare, about $150 to $200 a month, if your prescriber agrees.
• Brand-name drug with a ready-made plan: Hims, about $300 to $350 a month with its membership.
• You want coaching: Noom, about $180 a month, billed every 12 weeks.
• With insurance: look at full-dose Wegovy first. The savings card can bring it to $25 a month.

Mochi Health: the lowest monthly price

Mochi has a microdosing plan for compounded semaglutide. It is the cheapest step of its normal price ladder, since Mochi prices medicine by dose. Semaglutide starts at about $60 a month, plus about $80 for the membership. The first month of membership is free on the monthly plan.

Mochi works as a pharmacy marketplace, so these are floor prices that can vary. Paying a year of membership upfront brings the lowest dose to about $110 a month. Our Mochi Health review covers its pharmacies and reputation.

The Wegovy pill through NovoCare: brand-name, no membership

The Wegovy pill is a daily tablet of brand-name semaglutide. Its first two doses are 1.5 mg and 4 mg. NovoCare, Novo Nordisk's self-pay program, sells them for about $150 and $200 a month, with no membership.

The catch is that staying on those starting doses is off-label. You need a prescriber who agrees to it. Higher pill doses cost about $300 a month.

Hims: a brand-name Wegovy pill microdose plan

Hims sells a Wegovy pill microdosing plan. It starts at 1.5 mg and stops at 4 mg, and Hims calls it off-label. The pill costs about $150 to $200 a month, plus a membership of about $150. The first month of membership is $39. It is not offered in every state.

One thing to know: in July 2026, the FTC, Utah and California sued Hims & Hers over hard-to-cancel subscriptions and health-data sharing. The company denies the claims, and the case is pending. Our Hims review covers the details.

Noom: a microdose plan with coaching

Noom sells Microdose GLP-1Rx, separate from its standard plan. It defines a microdose as 25% or less of a typical maintenance dose. The first four weeks cost $79. After that it is about $180 a month, billed as about $535 every 12 weeks.

In May 2026, the ad industry's watchdog, the National Advertising Division, reviewed Noom's slogan "A Smaller Dose. A Smarter Start." It found the implied health benefit was not backed up and asked Noom to change or drop it.

Henry Meds: a microdose page, price set by plan

Henry Meds has a microdose page for compounded semaglutide shots. It says prices vary by plan and dose and start at $179 a month, with visits, medicine and supplies included. That $179 is Henry's general starting price, so ask for your microdose price before you pay.

Lemonaid Health: a dose cap of 25%

Lemonaid sells compounded semaglutide microdoses capped at 25% of the standard maintenance dose. The bill comes in two parts: about $200 for medicine and about $50 for membership, so about $250 a month.

Fridays: sold for wellness, not weight loss

Fridays sells a daily oral semaglutide blend in a separate Microdosing section, for about $250 a month. It markets it for energy and metabolic balance. Its own page says these compounded microdose formulas have not been studied for those outcomes. Our Fridays review covers the rest.

What about Ro? Its site sells brand-name GLP-1s, including the Wegovy pill and pen. It has an article about microdosing but lists no microdose plan.

Is there such a thing as a Wegovy microdose?

No. Wegovy is Novo Nordisk's brand of semaglutide for weight management. The shot comes in a single-dose pen with no dial, so it cannot be set lower or split. NovoCare sells Wegovy only at its approved doses.

Novo Nordisk's dose ladder has moved up, not down. In March 2026, the FDA approved a stronger 7.2 mg dose, called Wegovy HD, for people who need more than 2.4 mg.

So when an ad says "Wegovy microdosing," it almost always means compounded semaglutide. The only brand-name route is the Wegovy pill kept at its starting doses.

What does Wegovy-style microdosing cost per month and per year?

Here is a rough first year at a steady low dose:

• Mochi Health: about $1,600 to $1,700 at the lowest dose, or about $1,300 with a prepaid year of membership.
• Wegovy pill through NovoCare: about $1,800 a year at 1.5 mg, or about $2,400 at 4 mg.
• Henry Meds: about $2,150 at its $179 starting price. Your microdose plan may differ.
• Noom: about $2,230, counting the $79 start and four 12-week bills.
• Lemonaid Health and Fridays: about $3,000 each.
• Hims: about $3,450 at 1.5 mg to about $4,050 at 4 mg, membership included.

Full-dose brand-name Wegovy, for comparison:

• With insurance that covers Wegovy: as little as $25 a month with the savings card, about $325 a year. Nothing on this page beats it if you qualify.
• On Medicare: $50 a month through the GLP-1 Bridge, from July 2026 to December 2027, if you meet its rules.
• NovoCare pen, no insurance: about $4,240 in the first year. New patients pay about $200 for the first two fills through Dec 31, 2026, then about $350.
• List price, no program: about $1,350 a month. It is set to drop to $675 on Jan. 1, 2027.

None of these totals include lab tests. For every brand-name path, see Wegovy cost.

Is it legal to microdose Wegovy, or is this compounded semaglutide?

Online microdose plans are compounded semaglutide. No pharmacy can legally copy Wegovy and sell it under that name. A licensed pharmacy can make semaglutide for one patient on a prescription.

Novo Nordisk defends its brand name in court. In April 2025, it won a permanent injunction against one compounding pharmacy that sold knockoffs as Wegovy. A seller that calls its product "Wegovy microdosing" or "compounded Wegovy" is a warning sign.

The FDA ended the semaglutide shortage in February 2025, which ended mass compounding. On April 30, 2026, it also proposed not adding semaglutide, tirzepatide and liraglutide to the list that large outsourcing pharmacies, called 503B, can compound from. Comments closed July 30, 2026, with no final decision yet. That proposal does not affect a pharmacy making medicine for one patient.

How does Wegovy's real dose ladder compare to a microdose?

The Wegovy shot climbs in five steps to 2.4 mg over at least 16 weeks. A microdose usually means staying on the lowest steps, or below them.

The Wegovy pill has its own ladder, starting at 1.5 mg. For both schedules and missed doses, see the Wegovy dosage chart.

Is there evidence that microdosing works?

Not yet. In STEP 1, the trial behind Wegovy, people on 2.4 mg lost about 15% of their weight over 68 weeks, against about 2% on placebo. That trial tested the full dose, not a low one.

Harvard endocrinologist Dr. Jody Dushay wrote in STAT News in May 2026 that there are no legitimate long-term data behind microdosing. One registered trial of microdosed semaglutide is running, with no results posted yet.

Are side effects gentler at a lower dose?

Maybe, but it is not proven. In the Wegovy trials, nausea was worst right after each dose increase. A smaller, steady dose could mean fewer rough weeks.

Some doctors doubt it. Endocrinologist Dr. Ritu Anand told Hackensack Meridian Health in May 2026 that each new small step can feel like starting over. On results, expect less and less predictable weight loss than the trials showed.

Is a low dose a smart start for you in perimenopause?

Many women notice more nausea and bloating in perimenopause. So a gentle start is appealing, and a slower climb can mean fewer rough early weeks.

The trade-off is certainty. If real weight or metabolic change is the goal, climbing to Wegovy's studied dose has stronger evidence. A slower climb to that same dose is a middle path to raise with your prescriber.

Muscle matters more after 40, and GLP-1s and muscle loss in perimenopause covers how to protect it. For the hormone side, see GLP-1 medications and menopause weight gain.

How to tell a legitimate low-dose plan from a DIY red flag

What matters most is who manages the dose. A legitimate plan comes from a licensed prescriber and a named pharmacy. Your provider sets the dose and can change it.

Red flags look different. You split a Wegovy pen yourself. You buy an unlabeled microdosing kit online. Or you draw your own doses from a vial with no clear instructions.

The FDA has issued an alert on compounded semaglutide dosing errors. Most reports involved patients drawing too much from a multi-dose vial. Some injected 5 to 20 times their intended dose, and some needed hospital care.